NCT06090435

Brief Summary

Both motor imagery and action observation training, either alone or in combination with physical practice, have been shown to improve some clinical variables of interest such as strength and motor control. However, this has not yet been investigated in the pelvic floor musculature.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2023

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2023

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 19, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

October 19, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

October 3, 2023

Last Update Submit

October 16, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • maximal pelvic floor muscle strength (measured in grams and with the phenix device)

    Three measurements of maximal pelvic floor strength shall be performed with an intracavitary probe and the mean of the three measurements of maximal pelvic floor muscle strength shall be considered.

    pre-intervention (T0), at one week after the intervention (T1) and at two weeks after starting the intervention (post-intervention (T2)).

  • Algometry for assessing pressure pain thresholds (Pain sensitivity)

    An algometer shall be used to assess pain thresholds to pressure, i.e. squeezing so that pressure is converted into pain at four points. Two points in the symphysis pubis area, one point in the lumbar area and one point near the tibial tuberosity.

    pre-intervention (T0), at one week after the intervention (T1) and at two weeks after starting the intervention (post-intervention (T2)).

  • Motor control of the lumbopelvic area assessed with a biofeedback device.

    A protocol to assess lumbopelvic dissociation (i.e. moving the legs without moving the lower back) of both legs of the participants will be performed with a biofeedback device that assesses the pressure exerted on the lower back during leg mobilisation (in mmHg).

    pre-intervention (T0), at one week after the intervention (T1) and at two weeks after starting the intervention (post-intervention (T2)).

Study Arms (3)

Therapeutic exercise plus motor imagery

EXPERIMENTAL
Behavioral: Therapeutic exercise plus motor imagery

Therapeutic exercise plus action observation

EXPERIMENTAL
Behavioral: Therapeutic exercise plus action observation

Therapeutic exercise

ACTIVE COMPARATOR
Behavioral: Therapeutic exercise

Interventions

Therapeutic exercise programme (aerobic exercise and strengthening exercise) to which is added a motor imagery intervention (which consists of imagining the same movements but not performing them for real).

Therapeutic exercise plus motor imagery

Therapeutic exercise programme (aerobic exercise and strengthening exercise) to which is added an action observation intervention (which consists of observing the same movements but not performing them for real).

Therapeutic exercise plus action observation

Therapeutic exercise programme (aerobic exercise and strengthening exercise) to which is added a sham action observation intervention (which consists of observing planets in space).

Therapeutic exercise

Eligibility Criteria

Age18 Years - 30 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Over 18 years of age and asymptomatic women.

You may not qualify if:

  • This study will exclude those who presented a respiratory pathology, cardiac, systematic, or metabolic disease, history of recent surgery, vertebral fracture, or osteoarticular disorders of the spine area.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ferran Cuenca Martínez

Valencia, 46017, Spain

RECRUITING

MeSH Terms

Interventions

Exercise Therapy

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Ferran Cuenca Martínez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 3, 2023

First Posted

October 19, 2023

Study Start

September 30, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

October 19, 2023

Record last verified: 2023-10

Locations